Biotechnology
ImmVira Announces Series C Financing with Leading Specialist Investors
SHENZHEN, China, Dec. 31, 2020 /PRNewswire/ -- ImmVira Group Company ("the Company"), a biotechnology platform dedicated to the development of oncolytic virus("OV") and vector type approaches to create more effective and safer therapies against cancer, announced today the signing of Series C fina...
2020-12-31 19:29
3509
Novotech Health Holdings Appoints Zidong Zhang as CFO
SHANGHAI and SYDNEY, Dec. 28, 2020 /PRNewswire/ -- Novotech Health Holdings ("Novotech Holdings"), the largest biotech specialist contract research organization (CRO) inAsia, today announced the appointment of Zidong Zhang as Chief Financial Officer (CFO) effective4 January 2021. Zidong Zhang wil...
2020-12-29 12:00
1649
Arctic Vision obtains the first IND approval for the treatment of UME in China, Suprachoroidal space (SCS) injection potentially brings more benefits to patients
SHANGHAI, Dec. 25, 2020 /PRNewswire/ -- Arctic Vision, a China-based clinical-stage ophthalmology company with a leading portfolio of breakthrough technologies, announced on December 24th the clearance of the Investigational New Drug (IND) for Phase III trial of ARVN001 (triamcinolone acetonide s...
2020-12-25 21:00
3215
I-Mab Announces Upcoming Participation at January Conferences
SHANGHAI and GAITHERSBURG, Md., Dec. 23, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced its participation in the following conferences in Januar...
2020-12-23 21:00
5619
Hyundai Bioscience Develops Injection Drug for Potential Treatment of Severe Cases of COVID-19
SEOUL, South Korea, Dec. 22, 2020 /PRNewswire/ -- Hyundai Bioscience (KOSDAQ symbol: 048410) announced on the 23rd, December 2020, that CNPharm, its major shareholding bio tech company, has succeeded in developing 'Poly-COV01,' an injection drug for thepotential treatment of patients with severe ...
2020-12-23 10:09
1464
Origin Agritech Comments on Recent Regulatory Developments in China and Updates Shareholders on its Pipeline of Traits
BEIJING, Dec. 22, 2020 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), an agriculture technology company, today is updating shareholders on recent developments out ofChina regarding the path to GMO commercialization in the country and also on the status of the app...
2020-12-22 20:30
5175
Alterity and UniQuest partner to reverse bacterial resistance to antibiotics
MELBOURNE, Australia, Dec. 21, 2020 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") has today announced it has been granted a licence by UniQuest, the commercialisation company of The University of Queensland (UQ), to novel zinc ionophore technology to ...
2020-12-22 05:42
5528
Pierre Fabre Selects AGC Biologics as CDMO to manufacture the orphan drug ER-004
SEATTLE, Dec. 21, 2020 /PRNewswire/ -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced its partnership with Laboratoire Pierre Fabre to manufacture ER-004 – an intra-amniotic drug that will pioneer the treatment of a rare and...
2020-12-21 23:00
1429
Longevity Acquisition Corporation Announces 4D pharma Joining Landmark Parkinson's Progression Markers Initiative
NEW YORK, Dec. 21, 2020 /PRNewswire/ -- Longevity Acquisition Corporation (NASDAQ: LOAC) (the "Company"), a publicly-traded special purpose acquisition company, announced today that onDecember 18, 2020, 4D pharma plc (AIM: DDDD) ("4D pharma"), a pharmaceutical company leading the development of L...
2020-12-21 21:00
10697
Teijin Pharma and TransThera Biosciences Form Strategic R&D Collaboration
TOKYO and NANJING, China, Dec. 18, 2020 /PRNewswire/ -- Teijin Pharma Limited
2020-12-18 23:30
3245
Samsung Biologics Names John Rim as President and CEO
INCHEON, South Korea, Dec. 16, 2020 /PRNewswire/ -- Samsung Biologics (KRX:
207940.KS) announcedJohn Rim as its President and CEO. The appointment was made
effective immediately and formalized via the company's board of directors
meeting today.
2020-12-16 20:00
1282
Singlera Genomics raises $150 million in Series B financing to promote the development and commercialization of early cancer screening products
SAN DIEGO and SHANGHAI, Dec. 15, 2020 /PRNewswire/ -- Singlera Genomics Inc. today announced that it raised$150 million in Series B financing. This round of financing was led by the CICC Kai Tak Innovative Biomedicine Fund, and co-led by Detong Capital and Furong Investment. The new group of inve...
2020-12-15 22:00
1267
I-Mab Added to Nasdaq Biotechnology Index
SHANGHAI and GAITHERSBURG, Md., Dec. 14, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that I-Mab's American Depositary Shares (ADS) have been ...
2020-12-14 21:00
8449
Seegene's aggregated sales surpass KRW 1 tril. this year and plans on expanding annual production capacity to KRW 5 tril. in 2021
SEOUL, South Korea, Dec. 13, 2020 /PRNewswire/ -- South Korea's biotechnology company specializing in molecular diagnosis, Seegene Inc. (KQ096530), announced Monday that its aggregated sales this year have already surpassed theKRW 1 trillion mark, up nearly 10 times its previous annual sales of K...
2020-12-14 07:30
4266
PharmaBlock Enters Strategic Partnership with Ascentage Pharma
NANJING, China, Dec. 11, 2020 /PRNewswire/ -- PharmaBlock Sciences (Nanjing), Inc. (300725.SZ), a leading innovative chemistry product and service provider throughout the pharmaceutical R&D process, announced the signing of a strategic partnership agreement with Ascentage Pharma (6855.HK), a glob...
2020-12-11 21:00
6365
PharmAbcine presents the latest data of the ongoing Phase Ib mTNBC trial at SABCS 2020
DAEJEON, South Korea, Dec. 9, 2020 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of fully human antibody therapeutics, announced today the presentation of the latest interim data from its ongoing phase Ib combination trial of oli...
2020-12-09 23:00
1365
Hyundai Bioscience announced that its COVID-19 oral drug solved Niclosamide's inhibitory concentration problem
SEOUL, South Korea, Dec. 8, 2020 /PRNewswire/ -- Hyundai Bioscience (KOSDAQ symbol: 048410) released a report onDecember 8th that CP-COV03, its new COVID-19 oral drug candidate, successfully demonstrated a 100% inhibitory concentration level in the blood (IC100) for 12 hours against viral activit...
2020-12-08 21:00
1142
Peijia Medical Successfully Commenced Animal Study for its Mitral Valve Edge-to-Edge Repair Product
SUZHOU, China, Dec. 8, 2020 /PRNewswire/ -- Peijia Medical (HK Stock Code: 09996) successfully commenced the animal experiment for its mitral valve edge-to-edge repair product, advancing the development to the next stage. The commencement of this experiment reflects Peijia Medical's long term com...
2020-12-08 20:00
2969
Novotech Health Holdings Announces Appointment of Anand Tharmaratnam as Chairman
SHANGHAI and SYDNEY, Dec. 8, 2020 /PRNewswire/ -- Novotech Health Holdings ("Novotech Holdings"), the largest biotech specialist contract research organization (CRO) inAsia, today announced the appointment of Anand Tharmaratnam as Chairman of the Board commencing1 April 2021. Dr Tharmaratnam br...
2020-12-08 13:00
1236
Through Strategic Collaboration with GenScript ProBio, Initium Therapeutics Plans to Utilize GenScript ProBio's Berkeley Lights Beacon Platform to Expand Their Antibody Drug Pipeline
NANJING, China, Dec. 7, 2020 /PRNewswire/ -- On December 7, 2020, GenScript ProBio and Initium Therapeutics announced that Initium Therapeutics has launched a single B-cell based antibody development platform through collaboration with GenScript ProBio. Initium Therapeutics is a US biotechnology ...
2020-12-07 22:00
1451
Week's Top Stories
Most Reposted
Earth Day 2024: Angel Yeast Continues to Tackle Plastic Pollution Challenges With Bio-based Material Solutions
[Picked up by 289 media titles]
2024-04-22 16:00
Trina Solar and PetroGreen Partner to Accelerate Philippine Solar Adoption with 117MW Supply Agreement
[Picked up by 288 media titles]
2024-04-22 06:00
With unique features, Hainan TV opened "The World's Specialty" pavilion at the Expo!
[Picked up by 287 media titles]
2024-04-18 21:26
China's Yiwu Establishes Welcoming Committee to Attract International Buyers
[Picked up by 284 media titles]
2024-04-19 13:25
Animated Life in Yunnan
[Picked up by 280 media titles]
2024-04-18 14:00
Most Read
Combining Sustainability and Cybersecurity: Century Iron & Steel and Century Wind Power Both Receive ISO 27001 Information Security Certification
2024-04-19 18:03
7405
Animated Life in Yunnan
2024-04-18 14:00
7169
With unique features, Hainan TV opened "The World's Specialty" pavilion at the Expo!
2024-04-18 21:26
6947
China's Yiwu Establishes Welcoming Committee to Attract International Buyers
2024-04-19 13:25
5263
IQAX eBL Wins Prestigious APTFF Trade Facilitation Innovation Award 2024
2024-04-18 10:36
3596